We know from the analysis of the results that among these 12 genes, 3 genes, AURKA, CAV1, and CDKN2A, have the most significant differential expression in HNSCC patients (p < 0.0001, Figure 9). This evidence concerns the gene CDKN2A and head and neck squamous cell carcinoma.